ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2026
Primary Care Providers' Perspectives on Barriers and Facilitators to Human Papillomavirus (HPV) Vaccination among Young Adults: A Qualitative Study.
Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of a theory-based provider-focused training to improve HPV vaccine recommendations for young adults.Human vaccines & immunotherapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Young adults (18-26 years) are at high risk of human papillomavirus (HPV) exposure. Yet, HPV vaccine uptake is suboptimal among young adults. Provider recommendation is frequently the most influential factor in HPV vaccine acceptance. Evidence-based strategies are needed to facilitate provider recommendations for young adults. To inform provider-level strategies for recommending the HPV vaccine to young adult patients, the current study aims to understand current practices and barriers and facilitators to both recommending the HPV vaccine for young adults and for young adults to receive the HPV vaccine. Primary care providers (e.g., physicians, nurses; n = 15) in the United States completed a semi-structured interview guided by the Consolidated Framework for Implementation Research (CFIR). Data were analyzed thematically using Nvivo. Most participants identified as female (80%), White (67%), and non-Hispanic (93%). Participants reported varying their HPV vaccine discussions based on visit type (acute vs. wellness) and if the patient is new or established in their practice. Participants reported barriers to HPV vaccination in young adults across several CFIR domains including outer setting (e.g., transient living situation), inner setting (e.g., lack of availability of vaccine in clinic), individual (e.g., sex differences), and process (e.g., burnout). Facilitators included considering the HPV vaccine as a high priority and scheduling future vaccine appointments at the current visit. Evidence-based interventions to increase HPV vaccine uptake among young adults are needed. Healthcare providers identified multilevel barriers to both recommending and delivering the HPV vaccine to their young adult patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.